Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a newer build of the study detail page. This change affects only the page's metadata and does not alter the study content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNo longer looking for participants; new sections added for How to Read a Study Record, Common Questions, and How to Join a Study. Intervention/Treatment labeling was updated and the revision note changed to v3.6.0 from v3.5.5.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4, signaling a new version of the page without altering the study content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata. No other content changes are indicated.SummaryDifference0.1%

- Check71 days agoChange DetectedThis update changes the displayed site revision from v3.5.2 to v3.5.3 for the study details page, reflecting a platform/version release rather than any modification to the trial’s content.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.